Maclar 250 Tablet contains Clarithromycin 250 mg, a macrolide antibiotic effective against a broad spectrum of bacterial infections. It functions by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and replication. Maclar 250 is commonly prescribed for the treatment of respiratory tract infections such as bronchitis, pneumonia, and sinusitis, as well as skin and soft tissue infections, and Helicobacter pylori eradication in combination therapy for peptic ulcer disease. The dosage and duration of treatment depend on the type and severity of the infection, and it is essential to complete the full prescribed course to prevent the development of antibiotic resistance. Clarithromycin is generally well tolerated; however, patients may experience side effects including gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. Hypersensitivity reactions, taste disturbances, and headache have also been reported. Caution is advised in patients with hepatic or renal impairment, and potential drug interactions should be reviewed prior to initiation due to Clarithromycin’s effect on cytochrome P450 enzymes. Maclar 250 should be used under medical supervision, and patients should inform their healthcare provider of any pre-existing conditions or concurrent medications to ensure safe and effective treatment.